The Drug Development program represents a key innovation platform at PATH. Guided by a passion for health equity, we work with public- and private-sector stakeholders to develop and advance medicines for diseases disproportionately affecting women and children in low-resource settings. Areas of focus include enteric and diarrheal diseases, neglected tropical diseases, and maternal and child health.
Corporate author(s): PATH
Publication date: August 2017
105 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Global
- About PATH's work > PATH's areas of focus
- Drug Development > Drug development
- For advocates and policymakers > Public-private partnerships
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA